TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.

Pamela S Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.